Propanc Biopharma, Inc. (PPCB)

NASDAQ: PPCB · Real-Time Price · USD

1.010

-0.030 (-2.88%)

At close: Jul 31, 2026, 4:00 PM EDT

1.030

+0.020 (1.98%)

Pre-market: Aug 3, 2026, 9:03 AM EDT

Propanc Biopharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	0.44	0.01	0.02	0.01	0	0
Cash & Short-Term Investments	0.44	0.01	0.02	0.01	0	0
Cash Growth	774.12%	-42.67%	109.86%	147.04%	80.36%	-96.64%
Other Current Assets	7.78	8.34	0	0.01	0.01	0
Total Current Assets	8.22	8.35	0.03	0.02	0.02	0.01
Net Property, Plant & Equipment	0.05	0.06	0.02	0.04	0.06	0
Other Long-Term Assets	6.06	11.22	0.03	0	0	0
Total Assets	14.33	19.63	0.07	0.06	0.08	0.01

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Accounts Payable	0.97	1.25	1.24	1	0.97	1.04
Accrued Expenses	1.8	2.35	1.53	1.21	0.94	1.31
Short-Term Debt	0.52	1.56	0.87	0.51	0.98	0.68
Current Portion of Leases	0.02	0.02	0.02	0.02	0.02	-
Other Current Liabilities	0.15	0.4	0.13	0.42	0.15	0.05
Total Current Liabilities	3.48	5.58	3.79	3.16	3.06	3.08
Long-Term Debt	-	0.11	0.06	-	-	-
Long-Term Leases	0.03	0.04	-	0.02	0.04	-
Total Long-Term Liabilities	0.03	0.15	0.06	0.02	0.04	-
Total Liabilities	3.51	5.73	3.85	3.18	3.11	3.08

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Preferred Stock	-	-	-	-	0.01	0.01
Common Stock	0.05	0.01	0	0.01	0	0.01
Treasury Stock	-0.05	-0.05	-0.05	-0.05	-0.05	-0.05
Additional Paid-in Capital	149.43	138.24	61.7	60.31	57.34	54.07
Accumulated Other Comprehensive Income	1.23	1.32	1.27	1.29	1.23	1.09
Retained Earnings	-140.84	-125.62	-66.7	-64.68	-61.56	-58.2
Total Common Shareholders' Equity	9.83	13.91	-3.78	-3.12	-3.02	-3.07
Minority Interest	1	-	-	-	-	-
Shareholders' Equity	10.83	13.91	-3.78	-3.12	-3.02	-3.07
Total Liabilities & Equity	14.33	19.63	0.07	0.06	0.08	0.01

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Total Debt	0.57	1.73	0.95	0.55	1.04	0.68
Net Cash (Debt)	-0.13	-1.71	-0.93	-0.54	-1.04	-0.68
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.22	-10.80	-	-	-	-
Book Value	9.83	13.91	-3.78	-3.12	-3.02	-3.07
Book Value Per Share	16.45	87.61	-	-	-	-
Tangible Book Value	9.83	13.91	-3.78	-3.12	-3.02	-3.07
Tangible Book Value Per Share	16.45	87.61	-	-	-	-